Skip to main content
Donate

Standardized Electrophysiological Approaches for CA1 Field Recordings:

Insights into the AS Mouse Model

Melinda M Peters, Joseph E. Pick and Edwin J. Weeber

Published November 1, 2025

https://doi.org/10.65856/JJBD6749

KEYWORDS: Long-term potentiation, hippocampus, high frequency stimulation, animal models, synapse, synaptic function, synaptic plasticity.

ABSTRACT: The hippocampal CA3/CA1 Schaffer collateral pathway provides a lamina-resolved and highly reproducible synaptic pathway for quantifying synaptic transmission and plasticity in acute rodent brain slices. This paper consolidates best practices for CA1 field electrophysiology and links them to disease-relevant readouts in Angelman syndrome (AS) models. We detail a rigorously controlled pipeline spanning sucrose-based, low-Ca²⁺/high-Mg²⁺ cutting solutions; staged recovery from ice-cold to warmed (30–32 °C) artificial cerebrospinal fluid (ACSF); strict management of bicarbonate buffering to prevent divalent precipitation; and recording parameters that yield clean, minimally filtered field excitatory post-synaptic potentials (EPSPs). Quantification emphasizes the initial field excitatory post-synaptic potential (fEPSP) slope measured within a fixed, pre-registered window, normalization to a stable baseline, and exclusion criteria that guard against artifacts. We outline how input–output curves, establish basal synaptic gain and the operating point for plasticity assays, and we compare induction paradigms-consisting of classical 100 Hz high frequency stimulation (HFS), theta-frequency and theta-burst stimulation, and ultra-high-frequency stimulation. Applying this framework to AS mouse and rat models, we summarize how electrophysiology discriminates a shifted induction threshold from a true capacity deficit requiring restoration of downstream expression mechanisms or Ube3a function. The approach delivers a mechanistically interpretable, quantitative biomarker for AS that is suitable for preclinical screening and for testing gene-targeted and synaptic-level therapies. Collectively, these standardized practices, spanning anatomy, solutions, data acquisition, and analysis, establish a reproducible framework and a translational lens for interpreting hippocampal LTP in AS and other neurodevelopmental disease models.

DOWNLOAD PDF

FAST Angelman Syndrome News

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.